With mega merger season in full swing, Takeda officially swallows Shire

Amidst a flurry of multi-billion dollar mergers in 2019, the biggest-ever overseas acquisition by a Japanese drugmaker was consummated on Tuesday, as Takeda closed its $62 billion takeover of rare disease specialist Shire.